PULMATRIX, INC. Increase (Decrease) in Deferred Revenue
PULMATRIX, INC. (PULM) reported Increase (Decrease) in Deferred Revenue of -$4.34 million for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-09-17
- PULMATRIX, INC. increase (decrease) in deferred revenue for the quarter ending 2024-12-31 was $0.00.
- PULMATRIX, INC. increase (decrease) in deferred revenue for the quarter ending 2024-09-30 was -$270.00K.
- PULMATRIX, INC. increase (decrease) in deferred revenue for the quarter ending 2024-06-30 was -$93.00K.
- PULMATRIX, INC. increase (decrease) in deferred revenue for the quarter ending 2024-03-31 was -$3.98M.
- PULMATRIX, INC. increase (decrease) in deferred revenue for fiscal 2023 was -$1.82M.
- PULMATRIX, INC. increase (decrease) in deferred revenue for fiscal 2022 was -$847.00K.
- PULMATRIX, INC. increase (decrease) in deferred revenue for fiscal 2021 was -$3.33M.
- PULMATRIX, INC. increase (decrease) in deferred revenue for fiscal 2020 was -$10.96M, a 151.46% decline from fiscal 2019.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | -$270.00K derived: sum of 2 quarters · filed 2026-09-17 | -$363.00K derived: sum of 3 quarters · filed 2026-09-17 | -$4.34M S-4/A · filed 2026-09-17 |
| 2024-09-30 | -$270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-16 | -$363.00K derived: sum of 2 quarters · filed 2025-10-16 | -$4.34M 10-Q · filed 2025-10-16 | -$5.03M derived: sum of 4 quarters · filed 2025-10-16 |
| 2024-06-30 | -$93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$4.08M 10-Q · filed 2025-08-06 | -$4.76M derived: sum of 3 quarters · filed 2025-08-06 | -$5.19M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$3.98M 10-Q · filed 2025-05-15 | -$4.66M derived: sum of 2 quarters · filed 2025-05-15 | -$5.09M derived: sum of 3 quarters · filed 2025-05-15 | -$5.67M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$1.11M derived: sum of 2 quarters · filed 2025-03-21 | -$1.69M derived: sum of 3 quarters · filed 2025-03-21 | -$1.82M 10-K · filed 2025-03-21 |
| 2023-09-30 | -$430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$1.00M derived: sum of 2 quarters · filed 2024-11-08 | -$1.14M 10-Q · filed 2024-11-08 | -$1.19M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$574.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$705.00K 10-Q · filed 2024-08-13 | -$764.00K derived: sum of 3 quarters · filed 2024-08-13 | -$1.46M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$131.00K 10-Q · filed 2024-05-10 | -$190.00K derived: sum of 2 quarters · filed 2024-05-10 | -$889.00K derived: sum of 3 quarters · filed 2024-05-10 | -$1.23M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$758.00K derived: sum of 2 quarters · filed 2024-03-28 | -$1.09M derived: sum of 3 quarters · filed 2024-03-28 | -$847.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$699.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.04M derived: sum of 2 quarters · filed 2023-11-09 | -$788.00K 10-Q · filed 2023-11-09 | -$1.18M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$337.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$89.00K 10-Q · filed 2023-08-10 | -$478.00K derived: sum of 3 quarters · filed 2023-08-10 | -$1.54M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $248.00K 10-Q · filed 2023-05-12 | -$141.00K derived: sum of 2 quarters · filed 2023-05-12 | -$1.20M derived: sum of 3 quarters · filed 2023-05-12 | -$1.70M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.45M derived: sum of 2 quarters · filed 2023-03-30 | -$1.95M derived: sum of 3 quarters · filed 2023-03-30 | -$3.33M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.56M derived: sum of 2 quarters · filed 2022-11-10 | -$2.94M 10-Q · filed 2022-11-10 | -$4.85M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$1.88M 10-Q · filed 2022-08-10 | -$3.79M derived: sum of 3 quarters · filed 2022-08-10 | -$6.95M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$1.38M 10-Q · filed 2022-05-12 | -$3.30M derived: sum of 2 quarters · filed 2022-05-12 | -$6.45M derived: sum of 3 quarters · filed 2022-05-12 | -$9.60M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$5.07M derived: sum of 2 quarters · filed 2022-03-29 | -$8.22M derived: sum of 3 quarters · filed 2022-03-29 | -$10.96M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$3.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$6.30M derived: sum of 2 quarters · filed 2021-11-10 | -$9.04M 10-Q · filed 2021-11-10 | -$3.52M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$5.88M 10-Q · filed 2021-08-10 | -$369.00K derived: sum of 3 quarters · filed 2021-08-10 | -$1.77M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$2.74M 10-Q · filed 2021-05-11 | $2.78M derived: sum of 2 quarters · filed 2021-05-11 | $1.37M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | $5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $4.11M derived: sum of 2 quarters · filed 2021-03-23 | $21.29M 10-K · filed 2021-03-23 | |
| 2019-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $15.78M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $17.18M 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |